JP2005511748A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005511748A5 JP2005511748A5 JP2003551152A JP2003551152A JP2005511748A5 JP 2005511748 A5 JP2005511748 A5 JP 2005511748A5 JP 2003551152 A JP2003551152 A JP 2003551152A JP 2003551152 A JP2003551152 A JP 2003551152A JP 2005511748 A5 JP2005511748 A5 JP 2005511748A5
- Authority
- JP
- Japan
- Prior art keywords
- prior
- art
- compounds described
- compounds
- phosphodiesterases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0115971A FR2833266B1 (fr) | 2001-12-11 | 2001-12-11 | Nouveaux derives phosphonates, leur procede de preparation, leur utilisation comme modulateurs de l'activite des lymphocytes tgamma9 delta2 |
| PCT/FR2002/004190 WO2003050128A1 (fr) | 2001-12-11 | 2002-12-05 | PHOSPHONATES UTILES COMME MODULATEURS DE L'ACTIVITE DES LYMPHOCYTES t-GAMMA-9-DELTA-2 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005511748A JP2005511748A (ja) | 2005-04-28 |
| JP2005511748A5 true JP2005511748A5 (https=) | 2010-04-08 |
Family
ID=8870319
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003551152A Pending JP2005511748A (ja) | 2001-12-11 | 2002-12-05 | Ｔ−ガンマ−９−デルタ−２リンパ球の活性のモジュレーターとして有用なホスホネート |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20060241087A1 (https=) |
| EP (1) | EP1453840A1 (https=) |
| JP (1) | JP2005511748A (https=) |
| AU (1) | AU2002366577A1 (https=) |
| FR (1) | FR2833266B1 (https=) |
| WO (1) | WO2003050128A1 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0212666D0 (en) * | 2002-05-31 | 2002-07-10 | Secr Defence | Immunogenic sequences |
| WO2005054258A2 (en) * | 2003-12-02 | 2005-06-16 | Innate Pharma | New class of gamma delta t cells activators and use thereof |
| EP1720567A2 (en) * | 2004-02-10 | 2006-11-15 | Innate Pharma | Composition and method for the treatment of carcinoma |
| ATE419008T1 (de) * | 2004-04-26 | 2009-01-15 | Innate Pharma | Adjuvante zusammensetzung und anwendungsverfahren dafür |
| WO2006067635A2 (en) * | 2004-12-20 | 2006-06-29 | Innate Pharma S.A. | USE OF Ϝδ T LYMPHOCYTE ACTIVATORS AS VACCINE ADJUVANT |
| CA2602223A1 (en) * | 2005-03-22 | 2006-10-05 | Christian Belmant | New class of yo t cells activators and use thereof |
| US20090087456A1 (en) * | 2005-09-07 | 2009-04-02 | James Edward Eyles | Adjuvanted vaccine |
| AU2006298677A1 (en) * | 2005-10-06 | 2007-04-12 | Innate Pharma | Phosphoantigen salts of organic bases and methods for their crystallization |
| US8323664B2 (en) * | 2006-07-25 | 2012-12-04 | The Secretary Of State For Defence | Live vaccine strains of Francisella |
| WO2008059052A1 (en) | 2006-11-17 | 2008-05-22 | Innate Pharma | Improved methods of using phosphoantigen for the treatment of cancer |
| GB0906234D0 (en) | 2009-04-14 | 2009-05-20 | Secr Defence | Vaccine |
| AU2018384632B2 (en) | 2017-12-11 | 2021-10-21 | The Procter & Gamble Company | Oral care compositions comprising phosphonate and anionic group containing polymers |
| BR112020010126A2 (pt) * | 2017-12-11 | 2020-10-13 | The Procter & Gamble Company | composições para tratamento bucal que compreendem fosfono-fosfato e polímeros contendo grupo aniônico |
| US11008411B2 (en) | 2017-12-11 | 2021-05-18 | The Procter & Gamble Company | Phosphono-phosphate and anionic group containing polymers |
| WO2019118418A1 (en) | 2017-12-11 | 2019-06-20 | The Procter & Gamble Company | Method of making phosphono-phosphate containing compounds |
| US11046798B2 (en) | 2017-12-11 | 2021-06-29 | The Procter & Gamble Company | Phosphono-phosphate containing compounds and polymers |
| US11046817B2 (en) | 2017-12-11 | 2021-06-29 | The Procter & Gamble Company | Compositions comprising multi-valent cations and phosphono-phosphate containing polymers |
| JP7065513B2 (ja) * | 2018-06-29 | 2022-05-12 | 国立研究開発法人産業技術総合研究所 | 有機リン化合物 |
| CA3114292A1 (en) | 2018-09-27 | 2020-04-02 | Phosphogam, Inc. | Methods and compositions for the expansion and use of allogeneic gamma/delta-t cells |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR6914868D0 (pt) * | 1969-01-23 | 1973-03-20 | & Co Inc Merck | Processos quimicos |
| ZA774977B (en) * | 1976-09-06 | 1978-06-28 | Sab Soc Etudes Applic Biolog | Process for the preparation of 1,2-expoxypropyl-phosphonic acid derivatives |
| US4924024A (en) * | 1988-01-11 | 1990-05-08 | E. R. Squibb & Sons, Inc. | Phosphorus-containing squalene synthetase inhibitors, new intermediates and method |
| US5177239A (en) * | 1989-07-18 | 1993-01-05 | E. R. Squibb & Sons, Inc. | Method for preparing a phosphonic acid ester |
| US5298655A (en) * | 1991-09-27 | 1994-03-29 | Merck & Co., Inc. | Farnesyl pyrophosphate analogs |
| US5827838A (en) * | 1992-10-06 | 1998-10-27 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno & Rijksuniversteit Te Leiden | Method for the treatment of diseases related with protein isoprenylation |
| WO1994019357A1 (en) * | 1993-02-23 | 1994-09-01 | Merrell Dow Pharmaceuticals Inc. | Farnesyl:protein transferase inhibitors as anticancer agents |
| US5463181A (en) * | 1993-02-23 | 1995-10-31 | Merrell Dow Pharmaceuticals Inc. | Farnesyl: protein transferase inhibitors as anticancer agents |
| US5574025A (en) * | 1994-10-26 | 1996-11-12 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferases |
| IT1276162B1 (it) * | 1995-11-23 | 1997-10-27 | Baldacci Lab Spa | Geranilgeranil-derivati,procedimento per la loro preparazione e relative composizioni farmaceutiche |
| FR2782721B1 (fr) * | 1998-09-01 | 2000-11-03 | Inst Nat Sante Rech Med | Nouveaux composes phosphohalohydrines, procede de fabrication et applications |
| FR2782722B1 (fr) * | 1998-09-01 | 2001-01-12 | Inst Nat Sante Rech Med | Nouveaux composes phosphoepoxydes, procede de fabrication et applications |
| EP1153928B1 (en) * | 1999-01-21 | 2005-12-21 | Chugai Seiyaku Kabushiki Kaisha | 2-methyl-3-butenyl-1-pyrophosphoric acid salts and agents for treating lymphocytes |
| FR2791981B1 (fr) * | 1999-04-06 | 2001-07-20 | Inst Nat Sante Rech Med | Composes inhibant selectivement les lymphocytes tgamma9delta2, et leurs applications |
| EP1169996A1 (de) * | 2000-07-06 | 2002-01-09 | Ernst Mühlbauer Kg | Phosphonsäuren enthaltendes Dentalmaterial |
| DE10201458A1 (de) | 2001-04-11 | 2002-10-17 | Adelbert Bacher | Intermediate und Enzyme des Mevalonat-unabhängigen Isoprenoidbiosyntheseweg |
| WO2003009855A2 (de) * | 2001-07-20 | 2003-02-06 | Bioagency Ag | Organo-phosphorverbindungen zur aktivierung von gamma/delta-t-zellen |
-
2001
- 2001-12-11 FR FR0115971A patent/FR2833266B1/fr not_active Expired - Fee Related
-
2002
- 2002-12-05 US US10/498,313 patent/US20060241087A1/en not_active Abandoned
- 2002-12-05 AU AU2002366577A patent/AU2002366577A1/en not_active Abandoned
- 2002-12-05 JP JP2003551152A patent/JP2005511748A/ja active Pending
- 2002-12-05 EP EP02804596A patent/EP1453840A1/fr not_active Ceased
- 2002-12-05 WO PCT/FR2002/004190 patent/WO2003050128A1/fr not_active Ceased
-
2010
- 2010-01-14 US US12/656,049 patent/US8017596B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005511748A5 (https=) | ||
| USD498335S1 (en) | Exclusion cage for use with bird feeders | |
| AU2001272735A1 (en) | Novel physiologically active peptide and use thereof | |
| ATE425965T1 (de) | 1,2,3,4-tetrasubstituiertes indol zur behandlung von atemwegserkrankungen | |
| ATE390407T1 (de) | Phenethanolamin-derivate zur behandlung von atemwegserkrankungen | |
| CA2515596A1 (en) | Cannabinoid receptor ligands and uses thereof | |
| WO2005112945A3 (en) | Synthesis of tetracyclines and analogues thereof | |
| DE60311272D1 (de) | Neue purin- oder pyrrolol(2,3-d)pyrimidin-2-carbonsäurenitrile zur behandlung von mit cysteinproteaseaktivität assoziierten krankheiten | |
| DE60325209D1 (de) | Diarylharnstoffderivate, die sich zur behandlung von proteinkinaseabhängigen krankheiten eignen | |
| SG135192A1 (en) | Substituted pyrazoline compounds, their preparation and use as medicaments | |
| WO2005023083A3 (en) | Compositions and methods for the treatment of severe acute respiratory syndrome (sars) | |
| WO2003009855A3 (de) | Organo-phosphorverbindungen zur aktivierung von gamma/delta-t-zellen | |
| ATE281085T1 (de) | Nahrungsergänzung zur behandlung von makula degeneration | |
| ZA200409492B (en) | Compositions and methods for the diagnosis and treatment of tumor. | |
| ATE410430T1 (de) | 2,3-dihydro-6-nitroimidazoä2,1- büoxazolverbindungen zur behandlung von tuberkulose | |
| DE602006008641D1 (de) | Herstellung und anwendung von tetrahydropyrrolo ä3, 2-cüpyridin-4-onderivaten zur behandlung von obesitas und psychiatrischen und neurologischen erkrankungen | |
| USD507034S1 (en) | Fish hook design | |
| WO2006060809A3 (en) | Methods of using [3.2.0] heterocyclic compounds and analogs thereof | |
| CA2583764A1 (en) | Thrombopoietin activity modulating compounds and methods | |
| JP2005511619A5 (https=) | ||
| CA2489140A1 (en) | Dosage form containing pantoprazole as active ingredient | |
| JP2008513426A5 (https=) | ||
| WO2004056768A3 (en) | Use of substituted 2,5-diamidoindoles for the treatment of urological diseases | |
| PT1509085E (pt) | Fosfonatos e seus derivados como potenciadores da actividade de insecticidas | |
| JP2008513427A5 (https=) |